An autocrine IL-1β signaling loop has also been described for CD133+ CSCs mediating NF-κB signaling, EMT, and invasion in pancreatic cancer cell lines [110], and exposure to IL-1β induced motility and invasiveness in a non-invasive breast cancer cell line [97]. Here, IL1B is linked to breast carcinoma.